Park Medi World Limited — operator of the Park Hospitals brand — runs the second-largest private hospital chain in North India by bed capacity and the largest in Haryana. The network comprises 13 NABH-accredited hospitals (7 of which are NABL-accredited multi-super-specialty hospitals), 3,000 beds (including 805 ICU beds), 891 doctors and 1,912 nurses, and delivers 30+ super-specialty and specialty services across Haryana, Delhi, Punjab, and Rajasthan.

The company is raising $300M for 20% equity at a $1.5B valuation in a pre-IPO round. This values Park Medi World at approximately 10× FY24 top-line revenue — a material discount to Indian hospital-sector comparables which trade at 20–30× revenue (a recent South India hospital transacted at 30×). After the pre-IPO close, Park will proceed to a public listing, which management projects will double the equity valuation, giving pre-IPO investors a conservative 2–3× MOIC in a short horizon.

The investment thesis rests on three pillars: (1) scale in an underserved region — North India has bed density well below the National Health Policy threshold of 20 beds / 10,000 people, with Haryana at 13.5 and UP at 12–13; (2) proven M&A integration — 7 hospitals acquired and integrated, contributing ~41% of FY24 EBITDA at an aggregate consideration of INR 5.2bn; and (3) best-in-class profitability — Park's 25% EBITDA margin tops all listed Indian hospital peers (Fortis, Medanta, Max, Narayana, KIMS, Jupiter).

Park Hospitals was founded in 2005 by Dr. Ajit Gupta with the flagship 200-bed Park Hospital in New Delhi. From that single-hospital origin, Park has scaled — through a combination of greenfield builds and strategic acquisitions — to 13 hospitals and 3,000 beds across four states as of September 2024, with another 1,350 beds in the pipeline for commissioning by March 2028.

Park's competitive positioning is deliberate: high-quality affordable care for India's lower-middle and middle-class segments. The company delivers ~89% of its revenue through government health schemes and PSU panels, and complements cash-pay and insurance volumes with an ARPOB of INR 25,674 — the lowest among listed peers — while still generating 27% EBITDA margins (H1 FY25). This combination of lowest gross block per bed (INR 3.2M vs peer average of INR 9M) and highest margin efficiency is the core of the Park playbook.

The hospital network is concentrated in a tight cluster-based geography — Faridabad, Gurugram, Karnal, Panipat, Sonipat, Palam Vihar, Ambala, Behror, Patiala, Mohali, Jaipur, and New Delhi — allowing shared doctors, shared procurement, brand density, and referral flow between hospitals within driving distance of one another.

Five structural drivers underpin multi-year growth in the Park operating footprint:

• Government healthcare push — Ayushman Bharat covers 11+ crore families with INR 5 lakh assured coverage. Healthcare budget CAGR of 10% (FY11–FY25) with consistent 100%+ utilisation since FY16.
• Insurance penetration — from 40–42% (FY24) to 45–50% (FY26P), meaningfully expanding addressable private-pay demand.
• NCD prevalence — cardiovascular, cancer, and other non-communicable disease share of deaths rising from 66% (2019) to projected 77% (2030), directly expanding super-specialty demand.
• Medical tourism — 20% CAGR pre-COVID; projected to reach 720–730K medical tourists by 2024, supporting ARPOB uplift for network-grade hospitals.
• Supply gap — North India states (UP 12–13, Haryana/Rajasthan 13.5, Punjab 21–22) sit at or below the NHP benchmark of 20 beds per 10,000 population, giving disciplined operators multi-year expansion runway.